A Comprehensive Review of IgG4 Related Disease Unraveling the Role of B and T Lymphocytes in the Pathogenesis of the Disease

References

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012 Feb 9;366(6):539-51. doi: 10.1056/NEJMra1104650. PMID: 22316447.
2. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001 Mar 8;344(10):732-8. doi: 10.1056/NEJM200103083441005. PMID: 11236777.
3. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A, Egawa N, Nakajima H. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38(10):982-4. doi: 10.1007/s00535-003-1175-y. PMID: 14614606.
4. Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, Azumi A, Bloch DB, Brugge WR, Carruthers MN, Cheuk W, Cornell L, Castillo CF, Ferry JA, Forcione D, Klöppel G, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Masaki Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani D, Sato Y, Smyrk T, Stone JR, Takahira M, Umehara H, Webster G, Yamamoto M, Yi E, Yoshino T, Zamboni G, Zen Y, Chari S. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012 Oct;64(10):3061-7. doi: 10.1002/art.34593. PMID: 22736240; PMCID: PMC5963880.
5. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D; Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012 Feb;22(1):1-14. doi: 10.1007/s10165-011-0508-6. Epub 2011 Sep 1. PMID: 21881964; PMCID: PMC3278618.
6. Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ. 2020 Jun 16;369:m1067. doi: 10.1136/bmj.m1067. PMID: 32546500.
7. Wallace ZS, Miles G, Smolkina E, Petruski-Ivleva N, Madziva D, Cook C, Fu X, Zhang Y, Stone JH, Choi HK. Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults. Ann Rheum Dis. 2023 Jul;82(7):957-962. doi: 10.1136/ard-2023-223950. Epub 2023 May 3. PMID: 37137671.
8. Mirza N, Mehta S, Kumar K, Malhotra S, Sibal A. Clinical Profile of Acute Pancreatitis in Children and Adolescents from a Single Center in Northern India. J Indian Assoc Pediatr Surg. 2023 Jan-Feb;28(1):35-40. doi: 10.4103/jiaps.jiaps_36_22. Epub 2022 Dec 12. PMID: 36910284; PMCID: PMC9997585.
9. Ota M, Ito T, Umemura T, Katsuyama Y, Yoshizawa K, Hamano H, Kawa S. Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population. Dis Markers. 2011;31(4):223-9. doi: 10.3233/DMA-2011-0820. PMID: 22045429; PMCID: PMC3826803.
10. Umemura T, Ota M, Hamano H, Katsuyama Y, Muraki T, Arakura N, Kawa S, Kiyosawa K. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol. 2008 Mar;103(3):588-94. doi: 10.1111/j.1572-0241.2007.01750.x. PMID: 18341485.
11. Ota M, Katsuyama Y, Hamano H, Umemura T, Kimura A, Yoshizawa K, Kiyosawa K, Fukushima H, Bahram S, Inoko H, Kawa S. Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics. 2007 Jan;59(1):45-52. doi: 10.1007/s00251-006-0178-2. Epub 2006 Nov 21. PMID: 17119950.
12. Umemura T, Ota M, Hamano H, Katsuyama Y, Kiyosawa K, Kawa S. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut. 2006 Sep;55(9):1367-8. doi: 10.1136/gut.2006.095059. PMID: 16905709; PMCID: PMC1860039.
13. D'Astous-Gauthier K, Ebbo M, Chanez P, Schleinitz N. Implication of allergy and atopy in IgG4-related disease. World Allergy Organ J. 2023 Apr 17;16(4):100765. doi: 10.1016/j.waojou.2023.100765. PMID: 37179536; PMCID: PMC10172607.
14. Della-Torre E, Mancuso G, Lanzillotta M, Ramirez GA, Arcidiacono PG, Capurso G, Falconi M, Dagna L. Urgent manifestations of immunoglobulin G4-related disease. Scand J Rheumatol. 2021 Jan;50(1):48-51. doi: 10.1080/03009742.2020.1771763. Epub 2020 Jul 21. PMID: 32692264.
15. Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH; ACR/EULAR IgG4-RD Classification Criteria Committee. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 Mar;78(3):406-412. doi: 10.1136/annrheumdis-2018-214603. Epub 2019 Jan 5. PMID: 30612117; PMCID: PMC6996288.
16. Bal M, Deshpande V. Advancements in diagnosing IgG4-related disease of the head and neck: Navigating diagnostic pitfalls. Semin Diagn Pathol. 2024 Mar;41(2):54-65. doi: 10.1053/j.semdp.2023.12.003. Epub 2024 Jan 1. PMID: 38185595.
17. Bravo-Garrido G, Narro-Donate JM, Valdenebro-Cuadrado GM, Masegosa-González J. Lateral micro-orbitotomy as the technique of choice for orbital pseudotumor in IgG4-RD. Case report and review of the literature. Neurocirugia (Astur : Engl Ed). 2024 Jul-Aug;35(4):215-220. doi: 10.1016/j.neucie.2024.05.001. Epub 2024 May 25. PMID: 38801860.
18. Turner-Warwick R, Nabarro JD, Doniach D. Riedel's thyroiditis and retroperitoneal fibrosis. Proc R Soc Med. 1966 Jul;59(7):596-8. PMID: 5939497; PMCID: PMC1900982.
19. Thongpiya J, Eshak N, Yingchoncharoen P, Abdelnabi M. IgG4-related disease presents as a nasopharyngeal mass. BMJ Case Rep. 2023 Jul 31;16(7):e256043. doi: 10.1136/bcr-2023-256043. PMID: 37524512; PMCID: PMC10391819.
20. Saitakis G, Chwalisz BK. The neurology of IGG4-related disease. J Neurol Sci. 2021 May 15;424:117420. doi: 10.1016/j.jns.2021.117420. Epub 2021 Mar 27. PMID: 33845982.
21. Morales AT, Cignarella AG, Jabeen IS, Barkin JS, Mirsaeidi M. An update on IgG4-related lung disease. Eur J Intern Med. 2019 Aug;66:18-24. doi: 10.1016/j.ejim.2019.06.010. Epub 2019 Jun 19. PMID: 31227290. 72.
22. Ishida M, Hodohara K, Furuya A, Fujishiro A, Okuno H, Yoshii M, Horinouchi A, Shirakawa A, Harada A, Iwai M, Yoshida K, Kagotani A, Yoshida T, Okabe H. Concomitant occurrence of IgG4-related pleuritis and periaortitis: a case report with review of the literature. Int J Clin Exp Pathol. 2014 Jan 15;7(2):808-14. PMID: 24551308; PMCID: PMC3925932.
23. Jayachamarajapura Onkaramurthy N, Suresh SC, Theetha Kariyanna P, Jayarangaiah A, Prakash G, Raju B. IgG4 related disease and aortitis: an up-to-date review. Scand J Rheumatol. 2023 May;52(3):306-316. doi: 10.1080/03009742.2022.2145744. Epub 2023 Feb 10. PMID: 36763458.
24. Takanashi S, Akiyama M, Suzuki K, Otomo K, Takeuchi T. IgG4-related fibrosing mediastinitis diagnosed with computed tomography-guided percutaneous needle biopsy: Two case reports and a review of the literature. Medicine (Baltimore). 2018 Jun;97(22):e10935. doi: 10.1097/MD.0000000000010935. PMID: 29851832; PMCID: PMC6393095.
25. Löhr JM, Vujasinovic M, Rosendahl J, Stone JH, Beuers U. IgG4-related diseases of the digestive tract. Nat Rev Gastroenterol Hepatol. 2022 Mar;19(3):185-197. doi: 10.1038/s41575-021-00529-y. Epub 2021 Nov 8. PMID: 34750548.
26. Razok A, Romero Noboa ME, Sami F, Patolia KN, Tanveer S. IgG4-related disease and isolated retroperitoneal fibrosis: A narrative review. ARP Rheumatol. 2023 Apr-Jun;2(2):155-157. English. PMID: 37421192.
27. Kawano M, Saeki T, Nakashima H. IgG4-related kidney disease and retroperitoneal fibrosis: An update. Mod Rheumatol. 2019 Mar;29(2):231-239. doi: 10.1080/14397595.2018.1554321. Epub 2019 Jan 8. PMID: 30499730.
28. Mbengue M, Goumri N, Niang A. IgG4-related kidney disease: Pathogenesis, diagnosis, and treatment. Clin Nephrol. 2021 Jun;95(6):292-302. doi: 10.5414/CN110492. PMID: 33860756.
29. Nguyen T, Brodsky S, Maroz N. Progression to End-Stage Renal Disease Due to IgG4-Related Nephritis Refractory to Rituximab. Cureus. 2023 Mar 18;15(3):e36327. doi: 10.7759/cureus.36327. PMID: 37077588; PMCID: PMC10108657.
30. Gilani SI, Buglioni A, Cornell LD. IgG4-related kidney disease: Clinicopathologic features, differential diagnosis, and mimics. Semin Diagn Pathol. 2024 Mar;41(2):88-94. doi: 10.1053/j.semdp.2023.12.001. Epub 2023 Dec 20. PMID: 38246802.
31. Cheuk W, Bledsoe JR. IgG4-related lymphadenopathy. Semin Diagn Pathol. 2024 Mar;41(2):108-115. doi: 10.1053/j.semdp.2024.01.003. Epub 2024 Jan 5. PMID: 38228439.
32. Katerji R, Smoller BR. Immunoglobulin-G4-related skin disease. Clin Dermatol. 2021 Mar-Apr;39(2):283-290. doi: 10.1016/j.clindermatol.2020.10.009. Epub 2020 Oct 16. PMID: 34272023.
33. Sangoi AR, Maclean F, Myint E, Chan E. IgG4-Related Prostatitis: A Potentially Underappreciated Finding for Pathologists. Int J Surg Pathol. 2024 Feb;32(1):100-103. doi: 10.1177/10668969231171659. Epub 2023 May 4. PMID: 37143307.
34. Inoue D, Zen Y, Sato Y, Abo H, Demachi H, Uchiyama A, Gabata T, Matsui O. IgG4-Related Perineural Disease. Int J Rheumatol. 2012;2012:401890. doi: 10.1155/2012/401890. Epub 2012 Mar 18. PMID: 22523496; PMCID: PMC3317227.
35. Bateman AC, Culver EL. Challenges and pitfalls in the diagnosis of IgG4-related disease. Semin Diagn Pathol. 2024 Mar;41(2):45-53. doi: 10.1053/j.semdp.2023.11.005. Epub 2023 Nov 15. PMID: 38000975.
36. Stone JH, Brito-Zerón P, Bosch X, Ramos-Casals M. Diagnostic Approach to the Complexity of IgG4-Related Disease. Mayo Clin Proc. 2015 Jul;90(7):927-39. doi: 10.1016/j.mayocp.2015.03.020. PMID: 26141331.
37. Yamamoto M, Tabeya T, Naishiro Y, Yajima H, Ishigami K, Shimizu Y, Obara M, Suzuki C, Yamashita K, Yamamoto H, Hayashi T, Sasaki S, Sugaya T, Ishida T, Takano K, Himi T, Suzuki Y, Nishimoto N, Honda S, Takahashi H, Imai K, Shinomura Y. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol. 2012 Jun;22(3):419-25. doi: 10.1007/s10165-011-0532-6. Epub 2011 Sep 28. PMID: 21953287.
38. Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, Nakada S, Matsui S, Origuchi T, Nishiyama S, Yamada K, Kawano M, Hirabayashi A, Fujikawa K, Sugiura T, Horikoshi M, Umeda N, Minato H, Nakamura T, Iwao H, Nakajima A, Miki M, Sakai T, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, Eguchi K, Sugai S, Umehara H. Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease. Int J Rheumatol. 2012;2012:580814. doi: 10.1155/2012/580814. Epub 2012 May 10. PMID: 22654917; PMCID: PMC3357966.
39. Khosroshahi A, Cheryk LA, Carruthers MN, Edwards JA, Bloch DB, Stone JH. Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014 Jan;66(1):213-7. doi: 10.1002/art.38193. PMID: 24431286.
40. Wang H, Wang C, Wan Q, Li L. Roles of IgG4 and IgG4/IgG ratio to IgG4-related disease in patients with elevated serum IgG4 level. Clin Rheumatol. 2023 Mar;42(3):793-800. doi: 10.1007/s10067-022-06413-7. Epub 2022 Oct 28. PMID: 36305979.
41. Fujita Y, Fukui S, Umeda M, Tsuji S, Iwamoto N, Nakashima Y, Horai Y, Suzuki T, Okada A, Aramaki T, Ueki Y, Mizokami A, Origuchi T, Watanabe H, Migita K, Kawakami A. Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia. Front Immunol. 2022 Feb 24;13:828122. doi: 10.3389/fimmu.2022.828122. PMID: 35296071; PMCID: PMC8920547.
42. Ming B, Zhong J, Dong L. Role of eosinophilia in IgG4-related disease. Clin Exp Rheumatol. 2022 May;40(5):1038-1044. doi: 10.55563/clinexprheumatol/l7se2n. Epub 2021 Jul 30. PMID: 34369362.
43. Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015 Sep;67(9):2466-75. doi: 10.1002/art.39205. PMID: 25988916; PMCID: PMC4621270.
44. Maslinska M, Dmowska-Chalaba J, Jakubaszek M. The Role of IgG4 in Autoimmunity and Rheumatic Diseases. Front Immunol. 2022 Jan 25;12:787422. doi: 10.3389/fimmu.2021.787422. PMID: 35145508; PMCID: PMC8821096.
45. Tartakover Matalon S, Rabinowicz N, Carmi O, Zitman-Gal T, Drucker L, Levy Y. Examination of the Level of Circulating Plasmablasts and Their Characteristics as Diagnostic Tools for Immunoglobulin G4-related Disease. Isr Med Assoc J. 2024 Jun;26(6):369-375. PMID: 38884310.
46. Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD Responder Index. Int J Rheumatol. 2012;2012:259408. doi: 10.1155/2012/259408. Epub 2012 Apr 24. PMID: 22611406; PMCID: PMC3348627.
47. De Sainte Marie B, Urban ML, Vély F, Seguier J, Grados A, Daniel L, Ebbo M, Schleinitz N. Pathophysiology of IgG4-related disease: A T follicular helper cells disease? Presse Med. 2020 Apr;49(1):104013. doi: 10.1016/j.lpm.2020.104013. Epub 2020 Mar 29. PMID: 32234383.
48. Dragan AD, Weller A, Lingam RK. Imaging of IgG4-related disease in the extracranial head and neck. Eur J Radiol. 2021 Mar;136:109560. doi: 10.1016/j.ejrad.2021.109560. Epub 2021 Jan 27. PMID: 33524920.
49. Pucar D, Hinchcliff M. FDG PET vascular imaging in IgG4-RD: Potential and challenges. J Nucl Cardiol. 2022 Dec;29(6):2934-2937. doi: 10.1007/s12350-021-02887-1. Epub 2021 Dec 28. PMID: 34964084.
50. Muller R, Habert P, Ebbo M, Graveleau J, Groh M, Launay D, Audia S, Pugnet G, Cohen F, Perlat A, Benyamine A, Bienvenu B, Gaigne L, Chanez P, Gaubert JY, Schleinitz N. Thoracic involvement and imaging patterns in IgG4-related disease. Eur Respir Rev. 2021 Oct 5;30(162):210078. doi: 10.1183/16000617.0078-2021. PMID: 34615698; PMCID: PMC9488667.
51. Orozco-Gálvez O, Fernández-Codina A, Lanzillotta M, Ebbo M, Schleinitz N, Culver EL, Rebours V, D'Cruz DP, Della-Torre E, Martínez-Valle F. Development of an algorithm for IgG4-related disease management. Autoimmun Rev. 2023 Mar;22(3):103273. doi: 10.1016/j.autrev.2023.103273. Epub 2023 Jan 20. PMID: 36682575.
52. Bai Z, Zhou T, Yu Z, Chen Y, Dong L. Clinical value of 18F-FDG PET/CT in IgG4-related disease. Ann Nucl Med. 2022 Jul;36(7):651-660. doi: 10.1007/s12149-022-01749-1. Epub 2022 May 23. PMID: 35604531.
53. Huang YM, Lin PH. IgG4-Related Ophthalmic Disease. N Engl J Med. 2022 Jun 16;386(24):2315. doi: 10.1056/NEJMicm2116712. PMID: 35704484.
54. Towheed ST, Zanjir W, Ren KYM, Garland J, Clements-Baker M. Renal Manifestations of IgG4-Related Disease: A Concise Review. Int J Nephrol. 2024 Jun 24;2024:4421589. doi: 10.1155/2024/4421589. PMID: 38957780; PMCID: PMC11217581.
55. Imai S, Tahara N, Igata S, Tahara A, Bekki M, Sugiyama Y, Maeda-Ogata S, Honda A, Otsuka H, Ushijima T, Okabe Y, Kaida H, Abe T, Tanaka H, Fukumoto Y, Tayama E. Vascular/perivascular inflammation in IgG4-related disease. J Nucl Cardiol. 2022 Dec;29(6):2920-2933. doi: 10.1007/s12350-021-02812-6. Epub 2021 Oct 26. PMID: 34704218.
56. Saitakis G, Chwalisz BK. The neurology of IGG4-related disease. J Neurol Sci. 2021 May 15;424:117420. doi: 10.1016/j.jns.2021.117420. Epub 2021 Mar 27. PMID: 33845982.
57. Su WJ, Chang N, He HY. [IgG4-related diseases of retroperitoneum in urinary and male reproductive system: a clinicopathological analysis of eleven cases]. Zhonghua Bing Li Xue Za Zhi. 2022 Oct 8;51(10):970-975. Chinese. doi: 10.3760/cma.j.cn112151-20220325-00222. PMID: 36207908.
58. Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, Ishizaka N, Akamizu T, Sato Y, Kawano M; Research Program for Intractable Disease by the Ministry of Health, Labor and Welfare (MHLW) Japan.. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021 May;31(3):529-533. doi: 10.1080/14397595.2020.1859710. Epub 2021 Jan 28. PMID: 33274670.
59. Katz G, Stone JH. Clinical Perspectives on IgG4-Related Disease and Its Classification. Annu Rev Med. 2022 Jan 27;73:545-562. doi: 10.1146/annurev-med-050219-034449. Epub 2021 Oct 20. PMID: 34669430.
60. Bledsoe JR, Della-Torre E, Rovati L, Deshpande V. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS. 2018 Jun;126(6):459-476. doi: 10.1111/apm.12845. PMID: 29924455.
61. Zhang P, Zhang Y, Pan M, Liu Z, Li J, Peng L, Zhou J, Hu C, Liu S, Zeng X, Ge W, Zhang W. Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage. J Autoimmun. 2021 Aug;122:102650. doi: 10.1016/j.jaut.2021.102650. Epub 2021 Jun 6. PMID: 34107438.
62. Moriyama M, Nakamura S. Th1/Th2 Immune Balance and Other T Helper Subsets in IgG4-Related Disease. Curr Top Microbiol Immunol. 2017;401:75-83. doi: 10.1007/82_2016_40. PMID: 27744510.
63. Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, Deshpande V, Stone JH, Pillai S. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014 Sep;134(3):679-87. doi: 10.1016/j.jaci.2014.03.034. Epub 2014 May 6. PMID: 24815737; PMCID: PMC4149918.
64. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Klöppel G, Heathcote JG, Khosroshahi A, Ferry JA, Aalberse RC, Bloch DB, Brugge WR, Bateman AC, Carruthers MN, Chari ST, Cheuk W, Cornell LD, Fernandez-Del Castillo C, Forcione DG, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Lauwers GY, Masaki Y, Nakanuma Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani DV, Smyrk TC, Stone JR, Takahira M, Webster GJ, Yamamoto M, Zamboni G, Umehara H, Stone JH. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep;25(9):1181-92. doi: 10.1038/modpathol.2012.72. Epub 2012 May 18. PMID: 22596100.
65. Lis-López L, Bauset C, Seco-Cervera M, Cosín-Roger J. Is the Macrophage Phenotype Determinant for Fibrosis Development? Biomedicines. 2021 Nov 23;9(12):1747. doi: 10.3390/biomedicines9121747. PMID: 34944564; PMCID: PMC8698841.
66. Cai S, Chen Y, Hu Z, Zhou T, Huang Y, Lin S, Gao R, Zhong J, Dong L. The landscape of T and B lymphocytes interaction and synergistic effects of Th1 and Th2 type response in the involved tissue of IgG4-RD revealed by single cell transcriptome analysis. J Autoimmun. 2022 Dec;133:102944. doi: 10.1016/j.jaut.2022.102944. Epub 2022 Nov 16. PMID: 36401985.
67. Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020 Dec;16(12):702-714. doi: 10.1038/s41584-020-0500-7. Epub 2020 Sep 16. PMID: 32939060.
68. Chinju A, Moriyama M, Kakizoe-Ishiguro N, Chen H, Miyahara Y, Haque ASMR, Furusho K, Sakamoto M, Kai K, Kibe K, Hatakeyama-Furukawa S, Ito-Ohta M, Maehara T, Nakamura S. CD163+ M2 Macrophages Promote Fibrosis in IgG4-Related Disease Via Toll-like Receptor 7/Interleukin-1 Receptor-Associated Kinase 4/NF-κB Signaling. Arthritis Rheumatol. 2022 May;74(5):892-901. doi: 10.1002/art.42043. Epub 2022 Apr 10. PMID: 34907668; PMCID: PMC9322461.
69. Ming B, Zhong J, Dong L. Role of eosinophilia in IgG4-related disease. Clin Exp Rheumatol. 2022 May;40(5):1038-1044. doi: 10.55563/clinexprheumatol/l7se2n. Epub 2021 Jul 30. PMID: 34369362.
70. Aoyagi R, Maehara T, Koga R, Munemura R, Tomonaga T, Murakami Y, Doi A, Yamamoto H, Kiyoshima T, Kawano S, Nakamura S. Single-cell transcriptomics reveals granzyme K-expressing cytotoxic Tfh cells in tertiary lymphoid structures in IgG4-RD. J Allergy Clin Immunol. 2024 Feb;153(2):513-520.e10. doi: 10.1016/j.jaci.2023.08.019. Epub 2023 Aug 29. PMID: 37652139.
71. Chinju A, Moriyama M, Kakizoe-Ishiguro N, Chen H, Miyahara Y, Haque ASMR, Furusho K, Sakamoto M, Kai K, Kibe K, Hatakeyama-Furukawa S, Ito-Ohta M, Maehara T, Nakamura S. CD163+ M2 Macrophages Promote Fibrosis in IgG4-Related Disease Via Toll-like Receptor 7/Interleukin-1 Receptor-Associated Kinase 4/NF-κB Signaling. Arthritis Rheumatol. 2022 May;74(5):892-901. doi: 10.1002/art.42043. Epub 2022 Apr 10. PMID: 34907668; PMCID: PMC9322461.
72. Akiyama M, Suzuki K, Yasuoka H, Kaneko Y, Yamaoka K, Takeuchi T. Follicular helper T cells in the pathogenesis of IgG4-related disease. Rheumatology (Oxford). 2018 Feb 1;57(2):236-245. doi: 10.1093/rheumatology/kex171. PMID: 28460058.
73. Xu J, Zhai J, Zhao J. Pathogenic roles of follicular helper T cells in IgG4-related disease and implications for potential therapy. Front Immunol. 2024 Jun 7;15:1413860. doi: 10.3389/fimmu.2024.1413860. PMID: 38911857; PMCID: PMC11190345.
74. Yamamoto M, Tanaka T, Aochi S, Uehara M. HLA-DRB1 Is Associated with Therapeutic Responsiveness in IgG4-related Disease. Intern Med. 2024 Jan 15;63(2):207-211. doi: 10.2169/internalmedicine.1847-23. Epub 2023 May 24. PMID: 37225483; PMCID: PMC10864075.
75. Floreani A, Okazaki K, Uchida K, Gershwin ME. IgG4-related disease: Changing epidemiology and new thoughts on a multisystem disease. J Transl Autoimmun. 2020 Dec 19;4:100074. doi: 10.1016/j.jtauto.2020.100074. PMID: 33490938; PMCID: PMC7806798.
76. Detlefsen S, de Vos JD, Tanassi JT, Heegaard NHH, Fristrup C, Schaffalitzky de Muckadell OB. Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers for the differentiation of autoimmune pancreatitis and pancreatic cancer. Medicine (Baltimore). 2018 Aug;97(31):e11641. doi: 10.1097/MD.0000000000011641. PMID: 30075546; PMCID: PMC6081052.
77. Umehara H, Nakajima A, Nakamura T, Kawanami T, Tanaka M, Dong L, Kawano M. IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity. Int Immunol. 2014 Nov;26(11):585-95. doi: 10.1093/intimm/dxu074. Epub 2014 Jul 14. PMID: 25024397; PMCID: PMC4201844.
78. Kersten R, Trampert DC, Hubers LM, Tolenaars D, Vos HR, van de Graaf SFJ, Beuers U. Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids. Front Immunol. 2024 Jan 25;14:1251134. doi: 10.3389/fimmu.2023.1251134. PMID: 38332916; PMCID: PMC10851949.
79. Umehara H, Okazaki K, Kawano M, Tanaka Y. The front line of research into immunoglobin G4-related disease - Do autoantibodies cause immunoglobin G4-related disease? Mod Rheumatol. 2019 Mar;29(2):214-218. doi: 10.1080/14397595.2018.1558519. Epub 2019 Jan 17. PMID: 30557067.
80. Caba O, Diéguez-Castillo C, Martínez-Galán J, González-Cebrián I, Jiménez-Luna C. Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma. World J Gastrointest Oncol. 2023 Feb 15;15(2):268-275. doi: 10.4251/wjgo.v15.i2.268. PMID: 36908319; PMCID: PMC9994052.
81. Maslinska M, Dmowska-Chalaba J, Jakubaszek M. The Role of IgG4 in Autoimmunity and Rheumatic Diseases. Front Immunol. 2022 Jan 25;12:787422. doi: 10.3389/fimmu.2021.787422. PMID: 35145508; PMCID: PMC8821096.
82. Napodano C, Marino M, Stefanile A, Pocino K, Scatena R, Gulli F, Rapaccini GL, Delli Noci S, Capozio G, Rigante D, Basile U. Immunological Role of IgG Subclasses. Immunol Invest. 2021 May;50(4):427-444. doi: 10.1080/08820139.2020.1775643. Epub 2020 Jun 11. PMID: 32522062.
83. Zhang P, Wang M, Chen Y, Li J, Liu Z, Lu H, Fei Y, Feng R, Zhao Y, Zeng X, Zhang W. Expanded CD4+CXCR5-PD-1+ peripheral T helper like cells and clinical significance in IgG4-related disease. Clin Immunol. 2022 Apr;237:108975. doi: 10.1016/j.clim.2022.108975. Epub 2022 Mar 8. PMID: 35276322.
84. Yang Y, Wang C, Shi L, Yang S, Liu Y, Luo J, Wang C. Clinical Characteristics and CD4+ T Cell Subsets in IgG4-Related Disease. Front Immunol. 2022 Apr 1;13:825386. doi: 10.3389/fimmu.2022.825386. PMID: 35432312; PMCID: PMC9010737.
85. Mattoo H, Della-Torre E, Mahajan VS, Stone JH, Pillai S. Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy. Allergy. 2014 Mar;69(3):399-402. doi: 10.1111/all.12342. Epub 2013 Dec 31. PMID: 24382311; PMCID: PMC3944385.
86. Ito F, Kamekura R, Yamamoto M, Takano K, Takaki H, Yabe H, Ikegami I, Shigehara K, Himi T, Takahashi H, Ichimiya S. IL-10+ T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease. Immunol Lett. 2019 Mar;207:56-63. doi: 10.1016/j.imlet.2019.01.008. Epub 2019 Jan 15. PMID: 30658078.
87. Mattoo H, Mahajan VS, Maehara T, Deshpande V, Della-Torre E, Wallace ZS, Kulikova M, Drijvers JM, Daccache J, Carruthers MN, Castelino FV, Stone JR, Stone JH, Pillai S. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016 Sep;138(3):825-838. doi: 10.1016/j.jaci.2015.12.1330. Epub 2016 Mar 11. PMID: 26971690; PMCID: PMC5014627.
88. Perugino CA, Kaneko N, Maehara T, Mattoo H, Kers J, Allard-Chamard H, Mahajan VS, Liu H, Della-Torre E, Murphy SJH, Ghebremichael M, Wallace ZS, Bolster MB, Harvey LM, Mylvaganam G, Tuncay Y, Liang L, Montesi SB, Zhang X, Tinju A, Mochizuki K, Munemura R, Sakamoto M, Moriyama M, Nakamura S, Yosef N, Stone JH, Pillai S. CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. J Allergy Clin Immunol. 2021 Jan;147(1):368-382. doi: 10.1016/j.jaci.2020.05.022. Epub 2020 May 30. PMID: 32485263; PMCID: PMC7704943.
89. Akiyama M, Suzuki K, Kaneko Y, Takeuchi T. IgG4-Related Disease: A Growing Appreciation of Follicular Helper T Cell Expansion. Clin Transl Gastroenterol. 2019 Sep;10(9):e00076. doi: 10.14309/ctg.0000000000000076. PMID: 31517646; PMCID: PMC6775337.
90. Kamekura R, Takahashi H, Ichimiya S. New insights into IgG4-related disease: emerging new CD4+ T-cell subsets. Curr Opin Rheumatol. 2019 Jan;31(1):9-15. doi: 10.1097/BOR.0000000000000558. PMID: 30422824; PMCID: PMC6254779.
91. Mancuso G, Jofra T, Lanzillotta M, Aiuti A, Cicalese MP, di Colo G, Dagna L, Fousteri G, Della-Torre E. Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease. Rheumatology (Oxford). 2021 Aug 2;60(8):3947-3949. doi: 10.1093/rheumatology/keab344. PMID: 33856429.
92. Kubo S, Nakayamada S, Zhao J, Yoshikawa M, Miyazaki Y, Nawata A, Hirata S, Nakano K, Saito K, Tanaka Y. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease. Rheumatology (Oxford). 2018 Mar 1;57(3):514-524. doi: 10.1093/rheumatology/kex455. PMID: 29253269.
93. Chen Y, Lin W, Yang H, Wang M, Zhang P, Feng R, Chen H, Peng L, Zhang X, Zhao Y, Zeng X, Zhang F, Zhang W, Lipsky PE. Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4-Related Disease. Arthritis Rheumatol. 2018 Nov;70(11):1853-1865. doi: 10.1002/art.40556. Epub 2018 Aug 29. PMID: 29781221; PMCID: PMC6220938.
94. Lin W, Zhang P, Chen H, Chen Y, Yang H, Zheng W, Zhang X, Zhang F, Zhang W, Lipsky PE. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease. Arthritis Res Ther. 2017 Feb 10;19(1):25. doi: 10.1186/s13075-017-1231-2. PMID: 28183334; PMCID: PMC5301376.
95. Sage PT, Sharpe AH. The multifaceted functions of follicular regulatory T cells. Curr Opin Immunol. 2020 Dec;67:68-74. doi: 10.1016/j.coi.2020.10.009. Epub 2020 Oct 24. PMID: 33176227; PMCID: PMC7744352.
96. Wollenberg I, Agua-Doce A, Hernández A, Almeida C, Oliveira VG, Faro J, Graca L. Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells. J Immunol. 2011 Nov 1;187(9):4553-60. doi: 10.4049/jimmunol.1101328. Epub 2011 Oct 7. PMID: 21984700.
97. Rao DA, Gurish MF, Marshall JL, Slowikowski K, Fonseka CY, Liu Y, Donlin LT, Henderson LA, Wei K, Mizoguchi F, Teslovich NC, Weinblatt ME, Massarotti EM, Coblyn JS, Helfgott SM, Lee YC, Todd DJ, Bykerk VP, Goodman SM, Pernis AB, Ivashkiv LB, Karlson EW, Nigrovic PA, Filer A, Buckley CD, Lederer JA, Raychaudhuri S, Brenner MB. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017 Feb 1;542(7639):110-114. doi: 10.1038/nature20810. PMID: 28150777; PMCID: PMC5349321.
98. Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, Dent AL, Craft J, Crotty S. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science. 2009 Aug 21;325(5943):1006-10. doi: 10.1126/science.1175870. Epub 2009 Jul 16. PMID: 19608860; PMCID: PMC2766560.
99. Verstappen GM, Meiners PM, Corneth OBJ, Visser A, Arends S, Abdulahad WH, Hendriks RW, Vissink A, Kroese FGM, Bootsma H. Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome. Arthritis Rheumatol. 2017 Sep;69(9):1850-1861. doi: 10.1002/art.40165. Epub 2017 Aug 13. PMID: 28564491.
100. Kamekura R, Yamamoto M, Takano K, Yabe H, Ito F, Ikegami I, Takaki H, Shigehara K, Suzuki C, Himi T, Takahashi H, Ichimiya S. Circulating PD-1+CXCR5-CD4+ T cells underlying the immunological mechanisms of IgG4-related disease. Rheumatol Adv Pract. 2018 Oct 17;2(2):rky043. doi: 10.1093/rap/rky043. PMID: 31431980; PMCID: PMC6649940.
101. Cargill T, Barnes E, Culver EL. Expansion of a Novel Subset of PD1+CXCR5-CD4+ T Peripheral Helper Cells in IgG4-Related Disease. Clin Transl Gastroenterol. 2020 Jan;11(1):e00111. doi: 10.14309/ctg.0000000000000111. PMID: 31977453; PMCID: PMC7056044.
102. Zhang P, Wang M, Chen Y, Li J, Liu Z, Lu H, Fei Y, Feng R, Zhao Y, Zeng X, Zhang W. Expanded CD4+CXCR5-PD-1+ peripheral T helper like cells and clinical significance in IgG4-related disease. Clin Immunol. 2022 Apr;237:108975. doi: 10.1016/j.clim.2022.108975. Epub 2022 Mar 8. PMID: 35276322.
103. Liu J, Yin W, Westerberg LS, Lee P, Gong Q, Chen Y, Dong L, Liu C. Immune Dysregulation in IgG4-Related Disease. Front Immunol. 2021 Sep 1;12:738540. doi: 10.3389/fimmu.2021.738540. PMID: 34539675; PMCID: PMC8440903.
104. Tanaka Y, Stone JH. Perspectives on current and emerging therapies for immunoglobulin G4-related disease. Mod Rheumatol. 2023 Mar 2;33(2):229-236. doi: 10.1093/mr/roac141. PMID: 36408992.
105. Alsalamah NI, Alhrabi B, Alhumaily N, AlHadidi R, Basubrain LS, Al Asmari Z. Efficacy and Safety of Glucocorticoid Monotherapy Versus the Combination of Glucocorticoid and Immunosuppressive Agents for Immunoglobulin G4-Related Disease: A Systematic Review and Meta-Analysis. Cureus. 2023 Oct 16;15(10):e47099. doi: 10.7759/cureus.47099. PMID: 38022154; PMCID: PMC10646549.
106. Iaccarino L, Talarico R, Scirè CA, Amoura Z, Burmester G, Doria A, Faiz K, Frank C, Hachulla E, Hie M, Launay D, Montecucco C, Monti S, Mouthon L, Tincani A, Toniati P, Van Hagen PM, Van Vollenhoven RF, Bombardieri S, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Alexander T. IgG4-related diseases: state of the art on clinical practice guidelines. RMD Open. 2019 Jan 19;4(Suppl 1):e000787. doi: 10.1136/rmdopen-2018-000787. PMID: 30729031; PMCID: PMC6341179.
107. Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Löhr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH; Second International Symposium on IgG4-Related Disease. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132. PMID: 25809420.
108. Wallace ZS, Katz G, Hernandez-Barco YG, Baker MC. Current and future advances in practice: IgG4-related disease. Rheumatol Adv Pract. 2024 Apr 10;8(2):rkae020. doi: 10.1093/rap/rkae020. PMID: 38601138; PMCID: PMC11003820.
109. Tomiyama T, Uchida K, Matsushita M, Ikeura T, Fukui T, Takaoka M, Nishio A, Okazaki K. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol. 2011 May;46(5):696-704. doi: 10.1007/s00535-010-0361-y. Epub 2010 Dec 25. PMID: 21188426.
110. Yunyun F, Yu P, Panpan Z, Xia Z, Linyi P, Jiaxin Z, Li Z, Shangzhu Z, Jinjing L, Di W, Yamin L, Xiaowei L, Huadan X, Xuan Z, Xiaofeng Z, Fengchun Z, Yan Z, Wen Z. Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial. Rheumatology (Oxford). 2019 Jan 1;58(1):52-60. doi: 10.1093/rheumatology/key227. PMID: 30124952.
111. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010 Jun;62(6):1755-62. doi: 10.1002/art.27435. PMID: 20191576.
112. Adam Z, Dastych M, Čermák A, Doubková M, Skorkovská Š, Pour L, Řehák Z, Koukalová R, Adamová Z, Štork M, Krejčí M, Boichuk I, Král Z. Therapy of immunoglonuline IgG4 related disease (IgG4-RD). Vnitr Lek. 2022 Fall;68(E-6):15-22. English. doi: 10.36290/vnl.2022.086. PMID: 36316207.
113. Karim F, Paridaens D, Westenberg LEH, Guenoun J, Verdijk RM, van Hagen PM, van Laar JAM. Infliximab for IgG4-Related Orbital Disease. Ophthalmic Plast Reconstr Surg. 2017 May/Jun;33(3S Suppl 1):S162-S165. doi: 10.1097/IOP.0000000000000625. PMID: 26784550.
114. Kanda M, Kamekura R, Sugawara M, Nagahata K, Suzuki C, Takano K, Takahashi H. IgG4-related disease administered dupilumab: case series and review of the literature. RMD Open. 2023 Mar;9(1):e003026. doi: 10.1136/rmdopen-2023-003026. PMID: 36894196; PMCID: PMC10008221.
115. Ünlü S, Sánchez Navarro BG, Cakan E, Berchtold D, Meleka Hanna R, Vural S, Vural A, Meisel A, Fichtner ML. Exploring the depths of IgG4: insights into autoimmunity and novel treatments. Front Immunol. 2024 Apr 18;15:1346671. doi: 10.3389/fimmu.2024.1346671. PMID: 38698867; PMCID: PMC11063302.